DK0892852T3 - Indkapslede celler, som udtrykker cytochrom-P450 til pro-drug-aktivering - Google Patents

Indkapslede celler, som udtrykker cytochrom-P450 til pro-drug-aktivering

Info

Publication number
DK0892852T3
DK0892852T3 DK97919307T DK97919307T DK0892852T3 DK 0892852 T3 DK0892852 T3 DK 0892852T3 DK 97919307 T DK97919307 T DK 97919307T DK 97919307 T DK97919307 T DK 97919307T DK 0892852 T3 DK0892852 T3 DK 0892852T3
Authority
DK
Denmark
Prior art keywords
pro
cells expressing
encapsulated cells
drug activation
cytochrome
Prior art date
Application number
DK97919307T
Other languages
English (en)
Inventor
Walter H Guenzburg
Peter Karle
Robert Michael Saller
Original Assignee
Bavarian Nordic Res Inst As
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8092560&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0892852(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bavarian Nordic Res Inst As, Gsf Forschungszentrum Umwelt filed Critical Bavarian Nordic Res Inst As
Application granted granted Critical
Publication of DK0892852T3 publication Critical patent/DK0892852T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • C12N9/0079—Steroid 11 beta monooxygenase (P-450 protein)(1.14.15.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK97919307T 1996-03-27 1997-03-27 Indkapslede celler, som udtrykker cytochrom-P450 til pro-drug-aktivering DK0892852T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK35296 1996-03-27
EP97919307A EP0892852B1 (en) 1996-03-27 1997-03-27 Encapsulated cells expressing cytochrome p450 for prodrug activation

Publications (1)

Publication Number Publication Date
DK0892852T3 true DK0892852T3 (da) 2006-03-06

Family

ID=8092560

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97919307T DK0892852T3 (da) 1996-03-27 1997-03-27 Indkapslede celler, som udtrykker cytochrom-P450 til pro-drug-aktivering

Country Status (19)

Country Link
US (1) US6893634B1 (da)
EP (1) EP0892852B1 (da)
JP (1) JP4229982B2 (da)
AT (1) ATE309383T1 (da)
AU (1) AU713382B2 (da)
CA (1) CA2250173A1 (da)
CZ (1) CZ288074B6 (da)
DE (1) DE69730595D1 (da)
DK (1) DK0892852T3 (da)
ES (1) ES2253775T3 (da)
HU (1) HU221349B1 (da)
IL (1) IL125795A0 (da)
NO (1) NO325392B1 (da)
NZ (1) NZ331765A (da)
PL (1) PL188323B1 (da)
RU (2) RU2185821C2 (da)
SI (1) SI0892852T1 (da)
SK (1) SK282744B6 (da)
WO (1) WO1997035994A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE309000T1 (de) 1995-06-27 2005-11-15 Bavarian Nordic As Verkapselte zellen die virenpartikeln produzieren
RU2185821C2 (ru) 1996-03-27 2002-07-27 Бавариан Нордик Рисерч Инститьют А/С Трансдуцирующие цитохром р450 ретровирусные векторы
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
WO2000017366A2 (en) * 1998-09-21 2000-03-30 Transgene S.A. Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug
GB0400443D0 (en) 2004-01-09 2004-02-11 Oxford Biomedica Ltd Cascade
EP1141318B1 (en) * 1999-01-04 2006-07-05 Innovata PLC P450 / acetaminophen gdept for cancer treatment
GB9900009D0 (en) * 1999-01-04 1999-02-24 Ml Lab Plc Gene therapy
GB0010105D0 (en) * 2000-04-26 2000-06-14 Ml Lab Plc Cell ablation
WO2003025191A2 (en) * 2001-09-21 2003-03-27 Oxford Biomedica (Uk) Limited Pseudotyped retroviral vector system
GB201408233D0 (en) 2014-05-09 2014-06-25 Austrianova Singapore Pte Ltd Use of polyanionic composition
MX377487B (es) 2015-05-29 2025-03-04 Univ Mexico Nac Autonoma Nanoparticulas biocataliticas cyp-p22 con actividad citocromo p450 para la activacion de profarmacos.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1215922A (en) * 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
WO1989011539A1 (en) 1988-05-17 1989-11-30 Sloan-Kettering Institute For Cancer Research Retroviral vector
WO1994029437A1 (en) 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
RU2039593C1 (ru) * 1993-06-22 1995-07-20 Ф.А. Чернышкова Катализатор для получения фенола и ацетона
US5688773A (en) * 1994-08-17 1997-11-18 The General Hospital Corporation Method of selectively destroying neoplastic cells
CA2198210C (en) 1994-09-02 2006-07-11 Gsf - Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Non self-inactivating, expression targeted retroviral vectors
ATE309000T1 (de) 1995-06-27 2005-11-15 Bavarian Nordic As Verkapselte zellen die virenpartikeln produzieren
DK0848757T3 (da) * 1995-09-06 2002-07-01 Austrian Nordic Biotherapeutic Anvendelse af WAP eller MMTV regulatoriske sekvenser for målrettet ekspression af sammenkædede heterologe gener i humane mammae celler, inklusiv humane mammae carcinoma celler
RU2185821C2 (ru) 1996-03-27 2002-07-27 Бавариан Нордик Рисерч Инститьют А/С Трансдуцирующие цитохром р450 ретровирусные векторы

Also Published As

Publication number Publication date
RU2223788C2 (ru) 2004-02-20
PL188323B1 (pl) 2005-01-31
DE69730595D1 (de) 2004-10-14
HUP9904116A3 (en) 2001-01-29
WO1997035994A3 (en) 1997-11-20
EP0892852A2 (en) 1999-01-27
ATE309383T1 (de) 2005-11-15
NO325392B1 (no) 2008-04-21
AU2382797A (en) 1997-10-17
NZ331765A (en) 2000-02-28
CZ288074B6 (cs) 2001-04-11
IL125795A0 (en) 1999-04-11
RU2185821C2 (ru) 2002-07-27
CZ305098A3 (cs) 1999-01-13
HUP9904116A2 (hu) 2000-04-28
JP4229982B2 (ja) 2009-02-25
SI0892852T1 (sl) 2006-04-30
HU221349B1 (en) 2002-09-28
NO984540D0 (no) 1998-09-28
SK282744B6 (sk) 2002-12-03
PL329071A1 (en) 1999-03-15
JP2000509249A (ja) 2000-07-25
EP0892852B1 (en) 2005-11-09
US6893634B1 (en) 2005-05-17
ES2253775T3 (es) 2006-06-01
WO1997035994A2 (en) 1997-10-02
NO984540L (no) 1998-09-28
SK132398A3 (en) 1999-04-13
CA2250173A1 (en) 1997-10-02
AU713382B2 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
PY950041A (es) Compuesto de 1- fenil 3-dimetilamino- propano a procedimientos para su preparacion y a la aplicacion de estas sustancias en farmacologia
SE9801336D0 (sv) Enterala fluoxetin-piller
AU1534699A (en) Osmotic dosage form comprising first and second coats
DK1036058T3 (da) Adamantanderivater
DE69808130D1 (de) Adamantan-derivate
SI1194403T1 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
AR016827A1 (es) PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
SE9704546D0 (sv) Novel compounds
AR008991A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimientos para su preparacion y aplicacion de los mismos
AU2003286994A1 (en) Modified release pharmaceutical composition
NO973850D0 (no) Fenylsubstituerte alkenylkarboksylsyreguanidider; fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostika såvel som medikamenter inneholdende dem
DE3764595D1 (de) Herstellung einer gliedprothese und materialien, die dazu benoetigt werden.
SI0892852T1 (sl) Inkapsulirane celice, ki eksprimirajo citokrom P450 za aktiviranje predzdravila
DE68908313D1 (de) Klebverbaende, ihre herstellung und anwendung.
WO1991015512A3 (en) Hiv envelope polypeptides
DE60043442D1 (de) Ner aktiven phase und einer inaktiven phase
DK1119363T3 (da) Sammensætning, der indeholder carnetin- og inositolphosphat, egnet som kosttilskud eller lægemiddel
ES2139332T3 (es) Procedimiento para la preparacion del trihidrato del (2r,3s)-3-benzoilamino-2-hidroxi-3-fenilpropionato de 4,10-diacetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1,7beta-dihidroxi-9-oxo-tax-11-en-13alfa-ilo.
NO985571L (no) Legemiddel for autoimmunsykdommer
GT199900062A (es) Preparados efervescentes.
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
NO890096L (no) Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter.
ES2145979T3 (es) Procedimiento de redistribucion de policarbonatos.
WO2000017366A3 (en) Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug